Outbreak of yellow fever in central and southwestern Uganda, February–may 2016

Abstract

BackgroundOn 28 March, 2016, the Ministry of Health received a report on three deaths from an unknown disease characterized by fever, jaundice, and hemorrhage which occurred within a one-month period in the same family in central Uganda. We started an investigation to determine its nature and scope, identify risk factors, and to recommend eventually control measures for future prevention.MethodsWe defined a probable case as onset of unexplained fever plus ≥1 of the following unexplained symptoms: jaundice, unexplained bleeding, or liver function abnormalities. A confirmed case was a probable case with IgM or PCR positivity for yellow fever. We reviewed medical records and conducted active community case-finding. In a case-control study, we compared risk factors between case-patients and asymptomatic control-persons, frequency-matched by age, sex, and village. We used multivariate conditional logistic regression to evaluate risk factors. We also conducted entomological studies and environmental assessments.ResultsFrom February to May, we identified 42 case-persons (35 probable and seven confirmed), of whom 14 (33%) died. The attack rate (AR) was 2.6/100,000 for all affected districts, and highest in Masaka District (AR = 6.0/100,000). Men (AR = 4.0/100,000) were more affected than women (AR = 1.1/100,000) (p = 0.00016). Persons aged 30–39 years (AR = 14/100,000) were the most affected. Only 32 case-patients and 128 controls were used in the case control study. Twenty three case-persons (72%) and 32 control-persons (25%) farmed in swampy areas (ORadj = 7.5; 95%CI = 2.3–24); 20 case-patients (63%) and 32 control-persons (25%) who farmed reported presence of monkeys in agriculture fields (ORadj = 3.1, 95%CI = 1.1–8.6); and 20 case-patients (63%) and 35 control-persons (27%) farmed in forest areas (ORadj = 3.2; 95%CI = 0.93–11). No study participants reported yellow fever vaccination. Sylvatic monkeys and Aedes mosquitoes were identified in the nearby forest areas.ConclusionThis yellow fever outbreak was likely sylvatic and transmitted to a susceptible population probably by mosquito bites during farming in forest and swampy areas. A reactive vaccination campaign was conducted in the affected districts after the outbreak. We recommended introduction of yellow fever vaccine into the routine Uganda National Expanded Program on Immunization and enhanced yellow fever surveillance.

Could exotic mosquito-borne diseases emerge in Canada with climate change?

“…Other common MBDs of concern for returned travellers include yellow fever, Japanese encephalitis and lymphatic filariasis. The recent outbreaks of yellow fever in Brazil and parts of Africa are a threat for Canadian residents travelling in those regions (36)(37)(38), although confirmed cases in returned travellers remain low (14 cases between 2008 and 2016) (30) possibly due to the highly effective yellow fever vaccine recommended for Canadian travellers (39,40). The number of travel-acquired Japanese encephalitis and lymphatic filariasis cases is unknown as these diseases are not notifiable in Canada, but it is expected to be considerable given their high annual incidence globally (1).…”

Uganda public health fellowship program’s contribution to building a resilient and sustainable public health system in Uganda

“…Before PHFP, outbreak responses in Uganda typically had only minimal epidemiological investigation [16]. The commencement of PHFP brought systematic approaches to epidemiologic investigations in almost all outbreaks in Uganda [18][19][20]. As a result, PHFP has made the National Rapid Response Team more focused and enabled the MoH to control outbreaks in a shorter time period and at lower cost.…”

Disease Resurgence, Production Capability Issues and Safety Concerns in the Context of an Aging Population: Is There a Need for a New Yellow Fever Vaccine?

“…While the sylvatic and intermediate YFV transmission cycles account for most human disease, in the last decade there has been a resurgence in urban outbreaks [6]. Many of the recent African outbreaks, including in Uganda in 2010 [7,8], Ethiopia in 2013 [9], Angola in 2015 [10,11] and Nigeria in 2017 [12], were the first YF outbreaks in these countries in more than 10 years. Moreover, the Angola outbreak resulted in spread to the Democratic Republic of the Congo (DRC) [13], Mauritania and Kenya [14], as well as importation of disease into China by unvaccinated Chinese nationals who were infected while working in Angola [15,16].…”